Simulations Plus Inc is a premier provider of simulation and modelling software for pharmaceutical research. Known for its innovation, the company deploys its advanced technology to further drug discovery and development around the world.
Operating in the pharmaceutical and biotechnology sector, Simulations Plus offers highly sophisticated tools to aid in various aspects of research, with a focus on drug discovery and development. Simulations Plus is a singular entity without subsidiaries whose key offering is software that significantly aids in predicting the performance of drugs before costly and time-consuming tests are conducted.
Explore the movements of SLP share prices and other stocks on eToro.